Is 3jane Lending a Good Investment?
| TVL | $150K |
| FDV | — |
| TVL/FDV | — |
| Risk Grade | C+ |
| Value Grade | D |
Value Accrual: Does the 3jane Lending Token Capture Value?
3jane Lending scores D on Hindenrank's value accrual framework (22/100), indicating below-average value accrual with significant gaps in fee capture or sustainability. Fee capture scores 5/25 — limited, with most protocol revenue not yet accruing to the token. Token distribution is rated 5/25 (significantly concentrated among insiders or early investors), and emission sustainability sits at 5/25. The competitive moat dimension scores 7/25.
Protocol Health: Is 3jane Lending Still Growing?
3jane Lending's vitality risk score is 6/10 on Hindenrank's rubric (lower is healthier). This suggests moderate health — 3jane Lending is maintaining activity but may be showing signs of plateauing growth or reduced developer engagement. The protocol is functional but may not be accelerating.
Risk-Adjusted View: Is the Upside Worth the Risk?
Risk-Adjusted Position
Weak3jane Lending falls in the Weak quadrant — moderate risk (C+) with below-average value capture (D). The risk-reward is unfavorable at current levels, as the protocol does not compensate investors adequately for the risks they bear.
Risk Context
3jane Lending carries a risk grade of C+ (42/100), classified as elevated risk — multiple novel mechanisms and notable interaction risks. While no critical-severity interactions were identified, 2 high-severity interactions warrant attention. The primary risk factor is: 3Jane offers uncollateralized USDC credit lines underwritten by its 3CA algorithm, which combines on-chain data with off-chain credit scores via zkTLS. This is a fundamentally novel approach to DeFi lending where default risk is the primary concern — borrowers can take funds without posting collateral, and recovery depends on traditional legal enforcement and credit score penalties.
Read our full safety analysis →Where 3jane Lending Sits Among Lending Peers
On risk, 3jane Lending ranks #67 of 90 Lending protocols (below-median — riskier than average). That's 5 points riskier than the sector average of 37/100.
The closest peer by risk profile is Avalon Labs (grade C+, 42/100). See the side-by-side comparison to weigh their tradeoffs.
Should you buy 3jane Lending?
3jane Lending scores D on Hindenrank's value accrual framework, placing it among the below-average Lending protocols. Fee capture scores 5/25 — limited, with most protocol revenue not yet accruing to the token. Token distribution is significantly concentrated among insiders or early investors, and emission sustainability sits at 5/25. On the risk side, 3jane Lending carries a C+ grade (42/100), which is elevated risk — multiple novel mechanisms and notable interaction risks. The combined risk-value position places 3jane Lending in the Weak quadrant.
3jane Lending investment outlook for 2026
With $150,325 in total value locked, 3jane Lending's fundamentals do not strongly support the current valuation from a usage perspective. The competitive moat dimension scores 7/25, suggesting limited moat, leaving the protocol vulnerable to competitive pressure.Investors should weigh these fundamentals alongside market conditions and their own risk tolerance.
This analysis is based on cryptoeconomic fundamentals, not price prediction. It is not financial advice. Full methodology
Weekly Commentary
ProWeek of April 19, 2026
3Jane TVL declined significantly from $5M to $150K in the lending product since the March 2026 scan. No security exploits or shutdown announced; website and app remain operational. The protocol is a Paradigm and Coinbase Ventures-backed uncollateralized credit market on Base. The TVL decline likely reflects user risk-off behavior in high-risk lending products. Protocol vitality score updated to reflect reduced deposit activity.
Exploring options?
Compare Lending Alternatives →Related Lending Investment Analyses
Related Lending Safety Analyses
Get risk alerts before it's too late
Weekly grade changes, downgrade alerts, and new protocol risk findings. Free.